These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11489758)

  • 1. Alcoholism and risk for cancer of the cervix uteri, vagina, and vulva.
    Weiderpass E; Ye W; Tamimi R; Trichopolous D; Nyren O; Vainio H; Adami HO
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):899-901. PubMed ID: 11489758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
    Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
    Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correspondence re: Weiderpass et al., Alcoholism and risk of cancer of cervix uteri, vagina, and vulva. Cancer Epidemiol. Biomark. Prev., 10: 899-901, 2001.
    Chiaffarino F; Gallus S; Negri E; Parazzini F; Franceschi S; La Vecchia C
    Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):325-6. PubMed ID: 11895888
    [No Abstract]   [Full Text] [Related]  

  • 4. A population-based study of squamous cell vaginal cancer: HPV and cofactors.
    Daling JR; Madeleine MM; Schwartz SM; Shera KA; Carter JJ; McKnight B; Porter PL; Galloway DA; McDougall JK; Tamimi H
    Gynecol Oncol; 2002 Feb; 84(2):263-70. PubMed ID: 11812085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of 13 cases with vaginal intraepithelial neoplasia].
    Yang Y; Gao YL; Yu AJ; Zhang JJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Mar; 45(3):197-200. PubMed ID: 20450756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of invasive cervical cancer after three consecutive negative Pap smears.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex and genital cancer in heterosexual women.
    Singer A
    J Reprod Med; 1983 Feb; 28(2):109-15. PubMed ID: 6300392
    [No Abstract]   [Full Text] [Related]  

  • 12. [Incidence of precancerous states an carcinomas of the vulva in young women].
    Basta A; Adamek K; Pawlak M; Przeszlakowski D
    Przegl Lek; 1999; 56(1):20-2. PubMed ID: 10375919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding symptoms and subsequent risk of gynecological and other cancers.
    Viikki M; Pukkala E; Hakama M
    Acta Obstet Gynecol Scand; 1998 May; 77(5):564-9. PubMed ID: 9654181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of cancer among patients with atopic dermatitis.
    Hagströmer L; Ye W; Nyrén O; Emtestam L
    Arch Dermatol; 2005 Sep; 141(9):1123-7. PubMed ID: 16172309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second neoplasms after invasive and borderline ovarian cancer.
    Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
    Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia.
    Goodman MT; McDuffie K; Hernandez B; Wilkens LR; Bertram CC; Killeen J; Le Marchand L; Selhub J; Murphy S; Donlon TA
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1275-80. PubMed ID: 11751445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development.
    Gunnell AS; Tran TN; Torrång A; Dickman PW; Sparén P; Palmgren J; Ylitalo N
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2141-7. PubMed ID: 17057029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
    Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
    JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.
    Hawes SE; Critchlow CW; Faye Niang MA; Diouf MB; Diop A; Touré P; Aziz Kasse A; Dembele B; Salif Sow P; Coll-Seck AM; Kuypers JM; Kiviat NB
    J Infect Dis; 2003 Aug; 188(4):555-63. PubMed ID: 12898443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.